MSTN and age: The inhibition of myostatin signalling by anti‐myostatin antibodies or activin receptor inhibitors seems to be a great challenge to increase muscle mass in case of muscle wasting diseases, for example cancer‐associated cachexia, age‐related sarcopenia or plaster cast immobilization 53.